Picture of Dr. Lal PathLabs logo

LALPATHLAB — Dr. Lal PathLabs News Story

0.000.00%
in flag iconLast trade - 00:00
HealthcareBalancedMid CapHigh Flyer

Brief: Dr. Lal Pathlabs Approved The Re-Designation Of Shankha Banerjee By Appointing Him As CEO With Effect From May 21, 2024.

March 17 (Reuters) - Dr. Lal PathLabs Ltd  DLPA.NS :
    * APPROVED THE RE-DESIGNATION OF SHANKHA BANERJEE BY
APPOINTING
HIM AS CEO WITH EFFECT FROM MAY 21, 2024.

Source text for Eikon: [ID: nNSE6BBmpx]
Further company coverage:  DLPA.NS  

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Dr. Lal PathLabs

See all news